International Stem Cell CORP
ISCO· OTC
ISCOInternational Stem Cell CORP
Released Aug 11, 2023, during market hours
10-Q filed Aug 11, 2023, 42 days after period end · 0000950170-23-041762
No earnings release is on file for this quarter. Its figures came with the 10-Q.
| Metric | Q2 2023 | Q2 2022 | Q2 2021 | Q2 2020 |
|---|---|---|---|---|
| Revenue | $1.84M | $2.03M | $1.83M | $1.81M |
| Net Income | $492.00K | -$2.00K | $216.00K | -$1.09M |
| EPS Diluted | $0.03 |
International Stem Cell CORP · CIK 1355790 · Engraved from SEC EDGAR
| $0.00 |
| $0.03 |
| -$0.14 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
